Pfizer Inc.

PFE · CIK 0000078003

19 fiscal years · 68 SEC filings · every number carries its receipt

Revenue (FY)

$62.58B1.6%

FY2025

Net income (FY)

$7.77B3.2%

FY2025

Free cash flow (FY)

$9.07B7.7%

FY2025

Diluted EPS (FY)

$1.363.5%

FY2025

The story, charted

The shape of the business

FY2007–FY2025 · hover any year for its receipt

Revenue & net incomeRevenueNet income

revenue 1.3× since FY2007 · net margin 16.8% → 12.4%

MarginsNet marginFCF margin

FY2025: net 12.4% · free cash flow 14.5% of revenue

Cash engineOperating cash flowFree cash flow

FY2025: $11.70B operating cash − $2.63B capex = $9.07B free cash flow

Returns on capitalReturn on equityReturn on assets

return on equity 14% (FY2008) → 9% (FY2025) · on assets 3.7%

Balance sheetLiabilitiesEquity

FY2025: $208.16B assets · $121.39B liabilities · $86.48B equity

The receipts

Financial statements

Annual Quarterly (as reported)

USD in millions except per-share and share counts. Every value links to the filing it came from — hover for the us-gaap tag, click for the 10-K/10-Q on sec.gov.

USD millions	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014
Revenue	62,579	63,627	50,914	91,793	73,636	41,651	40,905	40,825	52,546	52,824	48,851	49,605
Net income	7,771	8,031	2,119	31,372	21,979	9,159	16,026	11,153	21,308	7,215	6,960	9,135
Diluted EPS	1.36	1.41	0.37	5.47	3.85	1.63	2.82	1.87	3.52	1.17	1.11	1.42
Diluted shares	5,713	5,700	5,709	5,733	5,708	5,632	5,675	5,977	6,058	6,159	6,257	6,424
Operating cash flow	11,704	12,744	8,700	29,267	32,580	14,403	12,588	15,827	16,802	16,192	14,688	17,084
Capital expenditures	2,629	2,909	3,907	3,236	2,711	2,226	2,046	1,984	1,956	1,823	1,397	1,199
Free cash flow	9,075	9,835	4,793	26,031	29,869	12,177	10,542	13,843	14,846	14,369	13,291	15,885
Cash & equivalents	1,142	1,043	2,853	416	1,944	1,786	1,121	1,139	1,342	2,595	3,641	3,343
Total assets	208,160	213,396	226,501	197,205	181,476	154,229	167,594	159,422	171,797	171,615	167,381	167,566
Total liabilities	121,385	124,899	137,213	101,288	104,013	90,756	104,148	95,664	100,141	111,776	102,384	95,944
Shareholders' equity	86,476	88,203	89,014	95,661	77,201	63,238	63,143	63,407	71,308	59,544	64,720	71,301

Figures as reported in SEC filings, normalized by stonks with the tag mapping shown on hover; missing tags render as “—”, never as zero. Free cash flow is derived (operating cash flow − capex) with both parents recorded in its lineage. See methodology.